Thousands of Ervebo vaccine doses arrive in Ebola-stricken DRC

The Ervebo vaccine is most effective against the Zaire strain of the Ebola virus, however the WHO said it may provide some protection against the current Bundibugyo strain.

Health authorities are warning that ‘approximately one person has been dying from Ebola every thirty minutes’.

More than 16,000 doses of the Ervebo vaccine arrived in the Democratic Republic of Congo (DRC) late Friday, an AFP journalist saw, as the country faces the deadliest Ebola outbreak in its history

Congo receives more than 16,000 doses of Ebola vaccine as it grapples with unprecedented outbreak  Toronto Star

Congo has received more than 16,000 doses of the Ervebo vaccine as the country grapples with the fastest Ebola outbreak in history, the country’s health minister said

Congo has received more than 16,000 doses of the Ervebo vaccine as the country grapples with the fastest Ebola outbreak in history, the country’s health minister said

Congo receives more than 16,000 doses of Ebola vaccine as it grapples with unprecedented outbreak  AP News

About half of the 2,500 recorded deaths from Ebola happened in the last 20 days, the WHO says.

[Premium Times] DRC receives 70,000 Ervebo vaccine doses, with 20,000 for a Phase III trial against Bundibugyo virus and 50,000 for frontline and health workers.

DRC receives 70,000 Ervebo vaccine doses, with 20,000 for a Phase III trial against Bundibugyo virus and 50,000 for frontline and health workers.

CONGO will receive 70,000 doses of the Ervebo vaccine, which has been effective in past Ebola outbreaks, the World Health Organisation (WHO) and partners said. The vaccine is licensed for use against Ebola virus, one of the viruses that cause Ebola disease, but not for Bundibugyo virus, which is responsible for the cur

By Chioma Obinna The Democratic Republic of the Congo, DRC, has secured an initial 70,000 doses of Ervebo vaccine from the global Ebola vaccine stockpile as health authorities intensify efforts to contain the ongoing Bundibugyo virus disease outbreak. The release followed a request by the DRC government to the Internat

WHO said in a statement that while it's not known whether Ervebo may protect against the Bundibugyo virus, "early laboratory and animal data suggest it may provide some protection."

Last week, the DRC had requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group (ICG) on Vaccine Provision.

The Ervebo vaccine is licensed for use against Ebola virus, one of the viruses that cause Ebola disease, but not for Bundibugyo virus.

The outbreak raging in six provinces in eastern Congo has infected and killed more people at a greater speed than any other Ebola outbreak in history.

The International Coordinating Group on Vaccine Provision, which includes the WHO and other partners, said the doses will be released immediately following a request from DR Congo’s government.

Congo will receive 70,000 doses of the Ervebo vaccine, which has been effective in past Ebola outbreaks, the World Health Organization (WHO) and partners said Thursday, announcing a step seen as a major boost to efforts to contain what officials have described as the fastest Ebola outbreak in history.

Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says  Reuters